Epidemiology, Evolution, and Pathogenesis of H7N9 Influenza Viruses in Five Epidemic Waves since 2013 in China

Trends in Microbiology

Volumn 25, Issue 9, 2017, Pages 713-728

  Su, Shuo ^a   Gu, Min ^b   Liu, Di ^d   Cui, Jie ^e   Gao, George F ^d,h   Zhou, Jiyong ^a,c,f   Liu, Xiufan ^b,g  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

^b YANGZHOU UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY   (China)

^d INSTITUTE OF MICROBIOLOGY   (China)

^e WUHAN INSTITUTE OF VIROLOGY   (China)

^f ZHEJIANG UNIVERSITY   (China)

^g Jiangsu Research Centre of Engineering and Technology for Prevention and Control of Poultry Disease   (China)

^h CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

evolution; five epidemic waves; H7N9 influenza virus; highly pathogenic

Indexed keywords

HEMAGGLUTININ; OSELTAMIVIR; PERAMIVIR; ZANAMIVIR; VIRUS HEMAGGLUTININ;

ADULT RESPIRATORY DISTRESS SYNDROME; CHICKEN; CHINA; DISEASE COURSE; DISEASE SEVERITY; DISEASE TRANSMISSION; EPIDEMIC; HEMAGGLUTININ GENE; HOST RESISTANCE; HUMAN; INFECTION CONTROL; INFLUENZA A; INFLUENZA A VIRUS (H7N9); NONHUMAN; PATHOGENESIS; PATHOGENICITY; PHYLOGENY; PNEUMONIA; PRIORITY JOURNAL; PUBLIC HEALTH; RECEPTOR BINDING; RESPIRATORY FAILURE; REVIEW; VIROLOGY; VIRUS MUTATION; ANIMAL; AVIAN INFLUENZA; GENETICS; INFLUENZA; MOLECULAR EVOLUTION; TRANSMISSION;

ANIMALS; CHICKENS; CHINA; DISEASE OUTBREAKS; EPIDEMICS; EVOLUTION, MOLECULAR; HEMAGGLUTININS, VIRAL; HUMANS; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; PUBLIC HEALTH;

EID: 85024833194     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2017.06.008     Document Type: Review

References (118)

1. Nelson, M.I., Vincent, A.L., Reverse zoonosis of influenza to swine: new perspectives on the human-animal interface. Trends Microbiol. 23 (2015), 142–153.
2. Gerber, M., et al. Selective packaging of the influenza A genome and consequences for genetic reassortment. Trends Microbiol. 22 (2014), 446–455.
3. Skehel, J.J., Hay, A.J., Influenza virus transcription. J. Gen. Virol. 39 (1978), 1–8.
4. Webster, R.G., et al. Evolution and ecology of influenza A viruses. Microbiol. Rev. 56 (1992), 152–179.
5. Su, S., et al. Characterization of H7N2 avian influenza virus in wild birds and pikas in Qinghai-Tibet Plateau area. Sci. Rep., 6, 2016, 30974.
6. Zhou, J., et al. Characterization of the H5N1 highly pathogenic avian influenza virus derived from wild pikas in China. J. Virol. 83 (2009), 8957–8964.
7. Zhou, J.Y., et al. Characterization of a highly pathogenic H5N1 influenza virus derived from bar-headed geese in China. J. Gen. Virol. 87 (2006), 1823–1833.
8. Su, S., et al. Epidemiology, evolution, and recent outbreaks of avian influenza virus in China. J. Virol. 89 (2015), 8671–8676.
9. Bui, C., et al. A systematic review of the comparative epidemiology of avian and human influenza A H5N1 and H7N9 – lessons and unanswered questions. Transbound. Emerg. Dis. 63 (2016), 602–620.
10. Beigel, J.H., et al. Avian influenza A (H5N1) infection in humans. N. Engl. J. Med. 353 (2005), 1374–1385.
11. Chan, P.K.S., Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997. Clin. Infect. Dis. 34 (2002), S58–S64.
12. Claas, E.C., et al. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 351 (1998), 472–477.
13. Gao, R., et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N. Engl. J. Med. 368 (2013), 1888–1897.
14. Chen, Y., et al. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet 381 (2013), 1916–1925.
15. Lam, T.T., et al. The genesis and source of the H7N9 influenza viruses causing human infections in China. Nature 502 (2013), 241–244.
16. Li, Q., et al. Epidemiology of human infections with avian influenza A(H7N9) virus in China. N. Engl. J. Med. 370 (2014), 520–532.
17. Li, Y., et al. Evolving HA and PB2 genes of influenza A (H7N9) viruses in the fifth wave – Increasing threat to both birds and humans?. J. Infect. 75 (2017), 184–186.
18. Huo, X., et al. Significantly elevated number of human infections with H7N9 virus in Jiangsu in eastern China, October 2016 to January 2017. Eurosurveillance 22 (2017), 5–14.
19. Zhu, H., et al. Emergence and development of H7N9 influenza viruses in China. Curr. Opin. Virol. 16 (2016), 106–113.
20. Guan, Y., Smith, G.J., The emergence and diversification of panzootic H5N1 influenza viruses. Virus Res. 178 (2013), 35–43.
21. Gu, M., et al. Enzootic genotype S of H9N2 avian influenza viruses donates internal genes to emerging zoonotic influenza viruses in China. Vet. Microbiol. 174 (2014), 309–315.
22. Mok, C.K., et al. Genetic characterization of highly pathogenic avian influenza A(H5N6) virus, Guangdong, China. Emerg. Infect. Dis. 21 (2015), 2268–2271.
23. Cheung, C.L., et al. Establishment of influenza a virus (H6N1) in minor poultry species in southern China. J. Virol. 81 (2007), 10402–10412.
24. Qi, W., et al. Genesis of the novel human-infecting influenza A(H10N8) virus and potential genetic diversity of the virus in poultry, China. Eurosurveillance 19 (2014), 50–62.
25. Zhang, F., et al. Human infections with recently-emerging highly pathogenic H7N9 avian influenza virus in China. J. Infect. 75 (2017), 71–75.
26. Gu, M., et al. Novel variants of clade 2.3.4 highly pathogenic avian influenza A(H5N1) viruses, China. Emerg. Infect. Dis. 19 (2013), 2021–2024.
27. Gu, M., et al. Novel reassortant highly pathogenic avian influenza (H5N5) viruses in domestic ducks, China. Emerg. Infect. Dis. 17 (2011), 1060–1063.
28. Zhao, K., et al. Characterization of three H5N5 and one H5N8 highly pathogenic avian influenza viruses in China. Vet. Microbiol. 163 (2013), 351–357.
29. Yu, Y., et al. Newly emergent highly pathogenic H5N9 subtype avian influenza A virus. J. Virol. 89 (2015), 8806–8815.
30. Wang, C.M., et al. Relationship between domestic and wild birds in live poultry market and a novel human H7N9 virus in China. J. Infect. Dis. 209 (2014), 34–37.
31. Wu, J., et al. Effect of live poultry market interventions on influenza A(H7N9) virus, Guangdong, China. Emerg. Infect. Dis. 22 (2016), 2104–2112.
32. Yu, H., et al. Effect of closure of live poultry markets on poultry-to-person transmission of avian influenza A H7N9 virus: an ecological study. Lancet 383 (2014), 541–548.
33. Gilbert, M., et al. Predicting the risk of avian influenza A H7N9 infection in live-poultry markets across Asia. Nat. Commun., 5, 2014, 4116.
34. Bao, C.J., et al. Live-animal markets and influenza A (H7N9) virus infection. N. Engl. J. Med. 368 (2013), 2337–2339.
35. Wu, J., et al. Seasonality of avian influenza A(H7N9) activity and risk of human A(H7N9) infections from live poultry markets. J. Infect. 71 (2015), 690–693.
36. Xie, S., et al. Third wave of influenza A(H7N9) virus from poultry, Guangdong Province, China, 2014–2015. Emerg. Infect. Dis. 21 (2015), 1657–1660.
37. Sun, Y., et al. Living poultry markets in rural area: Human infection with H7N9 virus re-emerges in Zhejiang Province, China, in winter 2014. J. Clin. Virol. 70 (2015), 16–22.
38. Lam, T.T.Y., et al. Dissemination, divergence and establishment of H7N9 influenza viruses in China. Nature 522 (2015), 102–U265.
39. Zhou, X.Y., et al. The role of live poultry movement and live bird market biosecurity in the epidemiology of influenza A (H7N9): A cross-sectional observational study in four eastern China provinces. J. Infect. 71 (2015), 470–479.
40. Su, S., et al. New ‘One Health’ strategies needed for detection and control of emerging pathogens at Cantonese live animal markets, China. Clin. Infect. Dis. 59 (2014), 1194–1197.
41. Bi, Y.H., et al. Genesis, evolution and prevalence of H5N6 avian influenza viruses in China. Cell Host Microbe 20 (2016), 810–821.
42. Wu, P., et al. Human infection with influenza A(H7N9) virus during 3 major epidemic waves, China, 2013–2015. Emerg. Infect. Dis. 22 (2016), 964–972.
43. Xiang, N.J., et al. Comparison of the first three waves of avian influenza A(H7N9) virus circulation in the mainland of the People's Republic of China. BMC Infect. Dis., 16, 2016, 734.
44. Farooqui, A., et al. Genetic diversity of the 2013-14 human isolates of influenza H7N9 in China. BMC Infect. Dis., 15, 2015, 109.
45. Watanabe, T., et al. Characterization of H7N9 influenza A viruses isolated from humans. Nature 501 (2013), 551–555.
46. Zhou, L., et al. Sudden increase in human infection with avian influenza A(H7N9) virus in China, September–December 2016. Western Pac. Surveill. Response J. 8 (2017), 6–14.
47. Liu, B., et al. Risk factors for influenza A(H7N9) disease – China, 2013. Clin. Infect. Dis. 59 (2014), 787–794.
48. Cowling, B.J., et al. Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases. Lancet 382 (2013), 129–137.
49. Wang, X., et al. Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013–17: an epidemiological study of laboratory-confirmed case series. Lancet Infect. Dis., 2017, 10.1016/S1473-3099(17)30323-7 Published online June 2, 2017.
50. Zhu, Y.F., et al. Human co-infection with novel avian influenza A H7N9 and influenza A H3N2 viruses in Jiangsu province, China. Lancet, 381, 2013 2134–2134.
51. Skowronski, D.M., et al. Avian influenza A(H7N9) virus infection in 2 travelers returning from China to Canada, January 2015. Emerg. Infect. Dis. 22 (2016), 71–74.
52. Wu, A., et al. Sequential reassortments underlie diverse influenza H7N9 genotypes in China. Cell Host Microbe 14 (2013), 446–452.
53. Cui, L.B., et al. Dynamic reassortments and genetic heterogeneity of the human-infecting influenza A (H7N9) virus. Nat. Commun., 5, 2014, 3142.
54. Wang, D., et al. Genetic tuning of the novel avian influenza A(H7N9) virus during interspecies transmission, China, 2013. Eurosurveillance 19 (2014), 33–49.
55. Wang, D.Y., et al. Two outbreak sources of influenza A (H7N9) viruses have been established in China. J. Virol. 90 (2016), 5561–5573.
56. Wang, X.Y., et al. Epidemiology of human infections with avian influenza A(H7N9) virus in the two waves before and after October 2013 in Zhejiang province, China. Epidemiol. Infect. 143 (2015), 1839–1845.
57. He, F., et al. Human infection and environmental contamination with Avian influenza A (H7N9) virus in Zhejiang Province, China: risk trend across the three waves of infection. BMC Public Health, 15, 2015, 931.
58. Chen, E., et al. Human infection with avian influenza A(H7N9) virus re-emerges in China in winter 2013. Eurosurveillance 18 (2013), 2–11.
59. Tu, C.Y., et al. The first case of avian influenza A (H7N9) virus occurring in the autumn season, China. Am. J. Infect. Control 42 (2014), 212–213.
60. Liu, D., et al. Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses. Lancet 381 (2013), 1926–1932.
61. Jin, Y., et al. Novel reassortment of avian influenza A(H7N9) virus with subtype H6N6 and H5N6 viruses circulating in Guangdong Province, China. J. Infect. 75 (2017), 179–182.
62. Shi, Y., et al. Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses. Science 342 (2013), 243–247.
63. Xiong, X., et al. Receptor binding by an H7N9 influenza virus from humans. Nature 499 (2013), 496–499.
64. Zhang, W., et al. Molecular basis of the receptor binding specificity switch of the hemagglutinins from both the 1918 and 2009 pandemic influenza A viruses by a D225G substitution. J. Virol. 87 (2013), 5949–5958.
65. Xie, J., et al. Epidemiological, clinical, and virologic features of two family clusters of avian influenza A (H7N9) virus infections in Southeast China. Sci. Rep., 7, 2017, 1512.
66. Yang, J.R., Liu, M.T., Human infection caused by an avian influenza A (H7N9) virus with a polybasic cleavage site in Taiwan, 2017. J. Formos. Med. Assoc. 116 (2017), 210–212.
67. Xiao, C., et al. PB2-588 V promotes the mammalian adaptation of H10N8, H7N9 and H9N2 avian influenza viruses. Sci. Rep., 6, 2016, 19474.
68. Wu, Y., et al. Characterization of two distinct neuraminidases from avian-origin human-infecting H7N9 influenza viruses. Cell Res. 23 (2013), 1347–1355.
69. Hay, A.J., Hayden, F.G., Oseltamivir resistance during treatment of H7N9 infection. Lancet 381 (2013), 2230–2232.
70. Hu, Y.W., et al. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet 381 (2013), 2273–2279.
71. Yen, H.L., et al. Resistance to neuraminidase inhibitors conferred by an R292K mutation in a human influenza virus H7N9 isolate can be masked by a mixed R/K viral population. mBio, 4, 2013 e00396-13.
72. Lin, P.H., et al. Virological, serological, and antiviral studies in an imported human case of avian influenza A(H7N9) virus in Taiwan. Clin. Infect. Dis. 58 (2014), 242–246.
73. Shen, Z., et al. Host immunological response and factors associated with clinical outcome in patients with the novel influenza A H7N9 infection. Clin. Microbiol. Infect. 20 (2014), O493–O500.
74. Marjuki, H., et al. Neuraminidase mutations conferring resistance to oseltamivir in influenza A(H7N9) viruses. J. Virol. 89 (2015), 5419–5426.
75. Song, M.S., et al. Unique determinants of neuraminidase inhibitor resistance among N3, N7, and N9 avian influenza viruses. J. Virol. 89 (2015), 10891–10900.
76. Colman, P.M., et al. Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature 303 (1983), 41–44.
77. Xiang, N., et al. Assessing change in avian influenza A(H7N9) virus infections during the fourth epidemic – China, September 2015–August 2016. Morb. Mortal. Wkly Rep. 65 (2016), 1390–1394.
78. Zhou, L., et al. Preliminary epidemiology of human infections with highly pathogenic avian influenza A(H7N9) virus, China, 2017. Emerg. Infect. Dis., 23(8), 2017.
79. Wang, X., et al. Seroprevalence to avian influenza A(H7N9) virus among poultry workers and the general population in Southern China: a longitudinal study. Clin. Infect. Dis. 59 (2014), E76–E83.
80. Yu, H., et al. Human infection with avian influenza A H7N9 virus: an assessment of clinical severity. Lancet 382 (2013), 138–145.
81. Cowling, B.J., et al. Preliminary inferences on the age-specific seriousness of human disease caused by avian influenza A(H7N9) infections in China, March to April 2013. Euro. Surveill., 18, 2013, 20475.
82. Zhu, et al. Biological characterisation of the emerged highly pathogenic avian influenza (HPAI) A (H7n9) viruses in humans, in mainland China, 2016 to 2017. Eurosurveillance, 2017, 10.2807/1560-7917.ES.2017.22.19.30533 Published online May 11, 2017.
83. Zhang, Q., et al. H7N9 influenza viruses are transmissible in ferrets by respiratory droplet. Science 341 (2013), 410–414.
84. Belser, J.A., et al. Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice. Nature 501 (2013), 556–559.
85. Tharakaraman, K., et al. Glycan receptor binding of the influenza A virus H7N9 hemagglutinin. Cell 153 (2013), 1486–1493.
86. Yang, H., et al. Structural analysis of the hemagglutinin from the recent 2013 H7N9 influenza virus. J. Virol. 87 (2013), 12433–12446.
87. Dortmans, J.C., et al. Adaptation of novel H7N9 influenza A virus to human receptors. Sci. Rep., 3, 2013, 3058.
88. Varghese, J.N., et al. Structural evidence for a second sialic acid binding site in avian influenza virus neuraminidases. Proc. Natl. Acad. Sci. U. S. A. 94 (1997), 11808–11812.
89. Air, G.M., Laver, W.G., Red cells bound to influenza virus N9 neuraminidase are not released by the N9 neuraminidase activity. Virology 211 (1995), 278–284.
90. Lin, Y.P., et al. Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment?. J. Virol. 84 (2010), 6769–6781.
91. Benton, D.J., et al. Role of neuraminidase in influenza A(H7N9) receptor binding. J. Virol. 91 (2017), e02293–16.
92. Liu, D., Gao, G.F., The new emerging H7N9 influenza virus indicates poultry as new mixing vessels. Sci. China Life Sci. 57 (2014), 731–732.
93. Gao, G.F., Influenza and the live poultry trade. Science, 344, 2014, 235.
94. Wu, Y., Gao, G.F., Lessons learnt from the human infections of avian-origin influenza A H7N9 virus: live free markets and human health. Sci. China Life Sci. 56 (2013), 493–494.
95. Bart, S.A., et al. A cell culture-derived MF59-adjuvanted pandemic A/H7N9 vaccine is immunogenic in adults. Sci. Transl. Med., 6, 2014, 234ra55.
96. Wang, Y., et al. A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice. Antiviral Res. 143 (2017), 97–105.
97. Bahl, K., et al. Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses. Mol. Ther., 25, 2017 1316–132.
98. De Groot, A.S., et al. Low immunogenicity predicted for emerging avian-origin H7N9: implication for influenza vaccine design. Hum. Vaccin. Immunother. 9 (2013), 950–956.
99. Bi, Y., et al. A new reassortment of influenza A (H7N9) virus causing human infection in Beijing, 2014. Sci. Rep., 6, 2016, 26624.
100. Ison, M.G., Antivirals and resistance: influenza virus. Curr. Opin. Virol. 1 (2011), 563–573.
101. Tharakaraman, K., et al. A broadly neutralizing human monoclonal antibody is effective against H7N9. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 10890–10895.
102. Wilson, J.R., et al. An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody with prophylactic and therapeutic activity in vivo. Antiviral Res. 135 (2016), 48–55.
103. Marjuki, H., et al. An investigational antiviral drug, DAS181, effectively inhibits replication of zoonotic influenza A virus subtype H7N9 and protects mice from lethality. J. Infect. Dis. 210 (2014), 435–440.
104. Morales, A.C. Jr., et al. Biologic characterization of H4, H6, and H9 type low pathogenicity avian influenza viruses from wild birds in chickens and turkeys. Avian Dis. 53 (2009), 552–562.
105. Spackman, E., et al. The pathogenesis of low pathogenicity H7 avian influenza viruses in chickens, ducks and turkeys. Virol. J., 7, 2010, 331.
106. Spackman, E., et al. Impact of route of exposure and challenge dose on the pathogenesis of H7N9 low pathogenicity avian influenza virus in chickens. Virology 477 (2015), 72–81.
107. Kalthoff, D., et al. Avian influenza H7N9/13 and H7N7/13: a comparative virulence study in chickens, pigeons, and ferrets. J. Virol. 88 (2014), 9153–9165.
108. Pantin-Jackwood, M.J., et al. Role of poultry in the spread of novel H7N9 influenza virus in China. J. Virol. 88 (2014), 5381–5390.
109. Belser, J.A., et al. Mammalian pathogenesis and transmission of H7N9 influenza viruses from three waves, 2013–2015. J. Virol. 90 (2016), 4647–4657.
110. Mok, C.K., et al. Pathogenicity of the novel A/H7N9 influenza virus in mice. mBio, 4, 2013 e00362–13.
111. Zhu, H., et al. Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science 341 (2013), 183–186.
112. Yum, J., et al. Low infectivity of a novel avian-origin H7N9 influenza virus in pigs. Arch. Virol. 159 (2014), 2745–2749.
113. Gabbard, J.D., et al. Novel H7N9 influenza virus shows low infectious dose, high growth rate, and efficient contact transmission in the guinea pig model. J. Virol. 88 (2014), 1502–1512.
114. Richard, M., et al. Limited airborne transmission of H7N9 influenza A virus between ferrets. Nature 501 (2013), 560–563.
115. Xu, L.L., et al. Novel avian-origin human influenza A(H7N9) can be transmitted between ferrets via respiratory droplets. J. Infect. Dis. 209 (2014), 551–556.
116. Ge, S., Wang, Z., An overview of influenza A virus receptors. Crit. Rev. Microbiol. 37 (2011), 157–165.
117. Suzuki, Y., et al. Sialic acid species as a determinant of the host range of influenza A viruses. J. Virol. 74 (2000), 11825–11831.
118. Suptawiwat, O., et al. A simple screening assay for receptor switching of avian influenza viruses. J. Clin. Virol. 42 (2008), 186–189.